The platelet, the patient, and periprocedural infarction during percutaneous transluminal coronary angioplasty.
作者信息
Fischman D L, Savage M P
出版信息
JAMA. 1997 Aug 13;278(6):518-9.
PMID:9256229
Abstract
摘要
相似文献
1
2
Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?经皮冠状动脉血运重建术中血小板糖蛋白IIb/IIIa抑制：还有哪些需要证实？
Eur Heart J. 2000 Jun;21(11):863-7. doi: 10.1053/euhj.1999.1975.
3
Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.冠状动脉血管成形术后血小板糖蛋白IIb/IIIa受体阻断
N Engl J Med. 1997 Oct 23;337(17):1243; author reply 1244-5. doi: 10.1056/NEJM199710233371716.
4
Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.冠状动脉血管成形术后血小板糖蛋白IIb/IIIa受体阻断
N Engl J Med. 1997 Oct 23;337(17):1243-4.
5
Care of the patient receiving ReoPro following angioplasty.
J Invasive Cardiol. 1994;6 Suppl A:38A-42A; discussion 54A-56A.
6
Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries.
J Invasive Cardiol. 2002 Dec;14 Suppl E:1E.
7
Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions.经皮冠状动脉介入治疗中血小板糖蛋白IIb/IIIa拮抗剂
Indian Heart J. 2000 Sep-Oct;52(5):524-32.
8
Minimally invasive bypass surgery.微创搭桥手术
N Engl J Med. 2002 Dec 26;347(26):2165-8; author reply 2165-8.
9
[Glycoprotein IIb/IIIa antagonists].[糖蛋白IIb/IIIa拮抗剂]
Med Monatsschr Pharm. 2000 Dec;23(12):385-90.
10
More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials.冠状动脉介入治疗期间血小板糖蛋白IIb/IIIa受体阻滞剂有益作用的更多证据。EPILOG和CAPTURE试验的最新结果。
Eur Heart J. 1996 Mar;17(3):325-6. doi: 10.1093/oxfordjournals.eurheartj.a014858.
引用本文的文献
1
Periprocedural creatine kinase-MB elevations: long-term impact and clinical implications.围手术期肌酸激酶-MB升高：长期影响及临床意义
Clin Cardiol. 1999 Apr;22(4):257-65. doi: 10.1002/clc.4960220403.
Zotero 插件